Tag Archives: John Newman

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN) and Mersana Therapeutics Inc (NASDAQ: MRSN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regeneron (NASDAQ:REGN) and Mersana Therapeutics Inc (NASDAQ:MRSN). Regeneron (REGN) Canaccord Genuity analyst John Newman maintained a Hold rating on Regeneron today and set

Analysts Are Bullish on These Healthcare Stocks: Bluebird Bio (BLUE), Nevro (NVRO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bluebird Bio (NASDAQ:BLUE) and Nevro (NYSE:NVRO) with bullish sentiments. Bluebird Bio (BLUE) In a report released today, John Newman from Canaccord Genuity

Analysts Are Bullish on Top Healthcare Stocks: Selecta Biosciences (SELB), SCYNEXIS (SCYX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Selecta Biosciences (NASDAQ:SELB) and SCYNEXIS (NASDAQ:SCYX) with bullish sentiments. Selecta Biosciences (SELB) In a report released today, John Newman from Canaccord Genuity

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Selecta Biosciences (NASDAQ: SELB) and Edwards Lifesciences (NYSE: EW)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Selecta Biosciences (NASDAQ: SELB) and Edwards Lifesciences (NYSE: EW). Selecta Biosciences (SELB) Canaccord Genuity analyst John Newman maintained a Buy rating on Selecta

Canaccord Genuity Thinks Celgene’s Stock is Going to Recover

In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Celgene (NASDAQ: CELG). The company’s shares opened today at $77.97, close to its 52-week low of $74.13. Newman observed: “We expect median Progression Free Survival

Canaccord Genuity Maintains Their Buy Rating on Atara Biotherapeutics

Canaccord Genuity analyst John Newman maintained a Buy rating on Atara Biotherapeutics (NASDAQ: ATRA) today and set a price target of $70. The company’s shares opened today at $39.53. According to TipRanks.com, Newman is a 5-star analyst with an average